New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 24, 2012
10:15 EDTAEO, BAK, BMY, FII, TCB, TRIP, USGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: American Eagle (AEO) upgraded to Neutral from Underperform at BofA/Merrill... Braskem (BAK) upgraded to Overweight from Neutral at HSBC... Bristol-Myers (BMY) upgraded to Buy from Neutral at BofA/Merrill... Federated Investors (FII) upgraded to Buy from Neutral at Citigroup... TCF Financial (TCB) upgraded to Outperform from Market Perform at BMO Capital... TripAdvisor (TRIP) upgraded to Buy from Neutral at Citigroup... USG (USG) upgraded to Buy from Neutral at Longbow.
News For AEO;BAK;BMY;FII;TCB;TRIP;USG From The Last 14 Days
Check below for free stories on AEO;BAK;BMY;FII;TCB;TRIP;USG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 21, 2013
07:34 EDTBMYUBS to host a conference
Subscribe for More Information
07:24 EDTBMYGlobal Health Care to host a conference
Subscribe for More Information
May 20, 2013
13:01 EDTTRIPPriceline.com rises after analyst ups rating to Buy
Subscribe for More Information
10:03 EDTBMYShire advances after report renews takeover speculation
Subscribe for More Information
06:30 EDTBMYLeerink estimates Shire takeout value at least $110 per share
Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire.
06:25 EDTBMYShire may return cash to thwart takeover, Daily Mail reports
Subscribe for More Information
05:51 EDTTRIPpriceline.com upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
May 17, 2013
13:21 EDTBMYOptions with increasing implied volatility: CPRT BMY GDI HNZ
Subscribe for More Information
May 16, 2013
16:32 EDTBMYBristol-Myers announces intention to voluntarily delist preferred stock
Subscribe for More Information
13:20 EDTBMYFollow-up: Bristol-Myers upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Bristol-Myers citing the company's multi-billion dollar immuno-oncology prospects. The firm says there were additional responses reported in the press briefing with combination nivolumab and Yervoy. Leerink has a $51 price target for shares.
13:14 EDTBMYBristol-Myers upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information
08:55 EDTBMYBofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call
Subscribe for More Information
08:38 EDTBMYBristol-Myers shares likely to give back recent gains, says Leerink
Leerink expects shares of Bristol-Myers to give back recent gains after ASCO published abstracts last night. The firm found the abstracts as in-line with, but not above, its expectations for nivolumab alone or immuno-oncology combination therapy and keeps a Market Perform rating on Bristol-Myers.
05:52 EDTBMYStocks with implied volatility movement; BMY SLV
Subscribe for More Information
May 15, 2013
11:28 EDTBMYOptions with increasing implied volatility: BMY AGNC EBIX IAU
Subscribe for More Information
09:49 EDTAEOAmerican Eagle upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information
09:43 EDTBMYActive equity option families trading on open
Subscribe for More Information
May 14, 2013
07:24 EDTBMYEBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16.
05:54 EDTUSGUSG management to meet with Buckingham
Meetings to be held in Baltimore, MD on May 14 and in Philadelphia on May 15 hosted by Buckingham.
May 10, 2013
11:59 EDTTRIPOptions with decreasing implied volatility: GRPN DGIT BMC BAX TRIP
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.